subgroup of
trial)
→
CapableOf
→
involve patient
| Typicality: | 0.379 |
| Saliency: | 0.000 |
| with metastatic melanoma | 2 | other |
| phase trial → involve → patient | 3 |
| negative | neutral | positive |
| 0.018 | 0.555 | 0.427 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.900 |
| Perplexity | 242.315 |